Nintedanib Plus mFOLFOX6 for Previously Untreated Metastatic Esophagogastric Adenocarcinoma (MEGAN)

NCT02856867 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

NETWORK

Sponsor class

Conditions

Esophagogastric Adenocarcinoma
Metastatic Disease
No Previous Chemotherapy for Metastatic Esophagogastric Cancer

Interventions

DRUG: Nintedanib
DRUG: Fluorouracil
DRUG: Leucovorin
DRUG: Oxaliplatin
DRUG: Placebo

Sponsor

European Organisation for Research and Treatment of Cancer - EORTC